Alzheimer's disease and related dementias in a diverse cohort of Asian Americans
Alzheimer's disease and related dementias in a diverse cohort of Asian Americans
批准号:
10000819
负责人:
Elizabeth Rose Mayeda
金额:
$46.86万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2023-04-30
关键词:
AddressAgeAlzheimer&aposs disease related dementiaAmericanAsian AmericansAsiansChinese AmericanChinese PeopleDataDiabetes MellitusDiagnosisDiscriminationEducationEducational BackgroundEthnic groupEuropeanFilipinoFilipino AmericanGenerationsGeneticGenotypeGoalsHealthHeterogeneityHispanic AmericansHypertensionImmigrantIncidenceIncomeIndividualJapanese AmericanJapanese PopulationMeasuresMedical RecordsNeighborhoodsPatternPhilippinesPopulation HeterogeneityPublic HealthRecording of previous eventsResearchResourcesRiskRisk FactorsRoleSamplingStrokeSurveysVariantapolipoprotein E-4cardiometabolismcohortdementia riskdiscountingdisparity reductionexperiencehealth planmemberneighborhood disadvantagepreventprotective factorsracial and ethnicsocialsocial factors
中文摘要
项目摘要
超过四分之一活到65岁的亚裔美国人可能会被诊断患有阿尔茨海默病
和相关痴呆症(ADRD),但亚裔美国人在ADRD研究中的代表性不足,
亚洲种族群体之间的风险异质性知之甚少。在最全面的研究中,
迄今为止,我们的研究小组发现,亚裔美国人之间的ADRD发病率存在显着差异,
菲律宾裔美国人的ADRD发病率比华裔美国人高27%。尽管少校
组间ADRD风险的差异,所有亚洲种族组的ADRD风险均低于非拉丁裔白人
(25非拉丁裔白人的比例高于亚裔美国人)。这些发现对公众健康有重大影响
影响:将所有种族/民族群体的ADRD率降低到亚裔美国人的水平,
在美国,每年预防> 190,000例ADRD病例,但目前尚不清楚为什么亚裔美国人的ADRD发病率降低了。
ADRD发病率或为什么亚洲种族群体不同。解开这些谜团将有助于我们理解
ADRD的决定因素在所有种族/民族背景的人,并帮助解决的主要差距,
对亚裔美国人健康驱动因素的研究,亚裔美国人是美国增长最快的种族/族裔群体。
本申请的目的是研究社会因素、心脏代谢健康和遗传因素
有助于降低亚裔美国人的ADRD风险和亚洲种族群体之间的风险差异(菲律宾人
美国人、华裔美国人和日裔美国人)。拟议研究的理由是,
描述亚裔美国人ADRD的风险和保护因素将揭示为什么亚裔美国人
ADRD风险低于其他种族/族裔群体,并确定预防ADRD和减少
ADRD差异。我们收集了调查数据,邻里信息,以及24年的医疗记录。
大约12,000名菲律宾人,日本人和华裔美国人凯撒健康计划成员的记录,
与非拉丁裔白人样本的比例为1:3此外,大约25%的样本具有基因型数据
available.这是亚裔美国人最大,最多样化的纵向样本,具有丰富的生物医学
以及与ADRD相关的社会数据。我们的具体目标是:1)评估社会因素的作用
(代际地位、教育程度、收入、邻里劣势指标、邻里
种族飞地)对亚裔美国人ADRD风险的影响; 2)评估心脏代谢健康(糖尿病,
高血压、中风)对亚裔美国人ADRD风险的影响; 3)确定遗传祖先和APOE是否
在亚裔美国人中观察到基因型影响ADRD发病率的变异。审视社会角色,
心脏代谢和遗传因素对亚裔美国人和白人的ADRD风险的影响
将提供有价值的信息,以预防所有种族/民族背景的人的ADRD,并减少ADRD
差距。
英文摘要
PROJECT SUMMARY
Over one in four Asian Americans who survive to age 65 can expect to be diagnosed with Alzheimer’s disease
and related dementias (ADRD), yet Asian Americans are under-represented in ADRD research, and
heterogeneity in risk across Asian ethnic groups is poorly understood. In the most comprehensive study to
date, our research team discovered marked differences in ADRD incidence between Asian American ethnic
groups (ADRD incidence was 27% higher in Filipino Americans than Chinese Americans). Despite the major
differences in ADRD risk between groups, all Asian ethnic groups had lower ADRD risk than non-Latino whites
(25% higher rate in non-Latino whites than Asian Americans). These findings have major public health
implications: reducing ADRD rates in all racial/ethnic groups to rates observed in Asian Americans would
prevent >190,000 ADRD cases annually in the U.S. Yet it is unknown why Asian Americans have lowered
ADRD incidence or why Asian ethnic groups differ. Disentangling these puzzles will inform our understanding
of the determinants of ADRD in people of all racial/ethnic backgrounds and help address the major gap in
research on drivers of health in Asian Americans, the fastest growing racial/ethnic group in the U.S. The overall
objective of this application is to examine how social factors, cardiometabolic health, and genetic factors
contribute to lower ADRD risk in Asian Americans and differences in risk between Asian ethnic groups (Filipino
Americans, Chinese Americans, and Japanese Americans). The rationale for the proposed research is that
delineating risk and protective factors for ADRD in Asian Americans will unlock why Asian Americans have
lower ADRD risk than other racial/ethnic groups and identify potential strategies to prevent ADRD and reduce
ADRD disparities. We have assembled survey data, neighborhood information, and 24 years of medical
records on ~12,000 Filipino, Japanese, and Chinese American Kaiser health plan members that will be
matched 1:3 to a sample of non-Latino whites. Further, approximately 25% of the sample has genotype data
available. This is the largest, most diverse longitudinal sample of Asian Americans with a rich set of biomedical
and social data relevant to ADRD available. Our Specific Aims are: 1) evaluate the role of social factors
(generational status, educational attainment, income, neighborhood disadvantage metrics, neighborhood
ethnic enclaves) on ADRD risk in Asian Americans; 2) evaluate the role of cardiometabolic health (diabetes,
hypertension, stroke) on ADRD risk in Asian Americans; 3) determine whether genetic ancestry and APOE
genotype influence variation in ADRD incidence observed in Asian Americans. Examining the roles of social,
cardiometabolic, and genetic factors on ADRD risk in a large, diverse cohort of Asian Americans and whites
will provide valuable information to prevent ADRD in people of all racial/ethnic backgrounds and reduce ADRD
disparities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimizing generalizability of biomarker studies for Alzheimer’s disease and related dementias with epidemiologic tools
-
批准号:10359225
-
项目类别:
-
资助金额:$58.25万
-
财政年份:2021
-
负责人:Elizabeth Rose Mayeda
-
依托单位:
Alzheimer's disease and related dementias in a diverse cohort of Asian Americans
-
批准号:10407959
-
项目类别:
-
资助金额:$49.87万
-
财政年份:2019
-
负责人:Elizabeth Rose Mayeda
-
依托单位:
Racial Disparities in Alzheimer's Disease and Related Dementias: The Role of Blood Pressure Throughout Adulthood
-
批准号:9164027
-
项目类别:
-
资助金额:$12.63万
-
财政年份:2016
-
负责人:Elizabeth Rose Mayeda
-
依托单位:
Racial Disparities in Alzheimer's Disease and Related Dementias: The Role of Blood Pressure Throughout Adulthood
-
批准号:9899176
-
项目类别:
-
资助金额:$22.4万
-
财政年份:2016
-
负责人:Elizabeth Rose Mayeda
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: